Revealed: Secret of HIV's natural born killers

June 10, 2012

Scientists on Sunday said they had found a key piece in the puzzle as to why a tiny minority of individuals infected with HIV have a natural ability to fight off the deadly AIDS virus.

In a study they said holds promise for an , researchers from four countries reported the secret lies not in the number of infection-killing cells a person has, but in how well they work.

Only about one person in 300 has the ability to control the (HIV) without drugs, using a strain of "killer" cells called cytotoxic T lymphocyte (CTL) cells, previous research has found.

Taking that discovery further, scientists from the United States, Canada, Japan and Germany reported that the strain has molecules called receptors that are better able to identify HIV-infected for attack.

Until now, it was well known that people with HIV "have tonnes of these ," Bruce Walker, an infectious diseases expert at the Ragon Institute in Massachusetts, told AFP.

"We have been scratching our heads since then, asking how, with so many killer cells around, people are getting AIDS. It turns out there is a special quality that makes them (some cells) better at killing."

The study looked at 10 infected people, of whom five took to keep HIV under control while five were so-called elite controllers who remained naturally healthy.

HIV kills a type of white blood cell called CD4, leaving people with AIDS wide open to other, opportunistic and potentially .

"What we found was that the way the killer cells are able to see infected cells and engage them was different," said Walker.

"It is not just that you need a killer cell, what you need is a killer cell with a (T cell) receptor that is particularly good at recognising the infected cell. This gives us a way to understand what it is that makes a really good killer cell."

Walker said attempts at creating vaccines had so far failed because the T they generated were not the efficient type.

But while the research has showed scientists how to find and measure the good cells, they still do not yet know how to generate them.

"The next step is to determine what it is about those receptors that is endowing them with that ability," said Walker.

"HIV has revealed another one of its secrets and that is how the body is able to effectively control the virus in certain individuals.

"Each secret that HIV reveals is putting us in a better position to ultimately make a vaccine to control the virus."

Explore further: Engineered stem cells seek out, kill HIV in living organisms

More information: Nature Immunology, DOI: 10.1038/ni.2342

Related Stories

Engineered stem cells seek out, kill HIV in living organisms

April 12, 2012
(Medical Xpress) -- Expanding on previous research providing proof-of-principal that human stem cells can be genetically engineered into HIV-fighting cells, a team of UCLA researchers have now demonstrated that these cells ...

Unraveling the mysteries of the natural killer within us

October 24, 2011
Scientists have discovered more about the intricacies of the immune system in a breakthrough that may help combat viral infections such as HIV.

Recommended for you

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

New research opens the door to 'functional cure' for HIV

October 17, 2017
In findings that open the door to a completely different approach to curing HIV infections, scientists from the Florida campus of The Scripps Research Institute (TSRI) have for the first time shown that a novel compound effectively ...

Researchers create molecule that could 'kick and kill' HIV

October 5, 2017
Current anti-AIDS drugs are highly effective at making HIV undetectable and allowing people with the virus to live longer, healthier lives. The treatments, a class of medications called antiretroviral therapy, also greatly ...

A sixth of new HIV patients in Europe 50 or older: study

September 27, 2017
People aged 50 and older comprise a growing percentage of HIV patients in Europe, accounting for one in six new cases in 2015, researchers said Wednesday.

Three-in-one antibody protects monkeys from HIV-like virus

September 20, 2017
A three-pronged antibody made in the laboratory protected monkeys from infection with two strains of SHIV, a monkey form of HIV, better than individual natural antibodies from which the engineered antibody is derived, researchers ...

Fighting HIV on multiple fronts might lead to vaccine

September 20, 2017
A combination antibody strategy could be the key to halting the spread of HIV, according to results from two promising animal studies.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

baudrunner
not rated yet Jun 11, 2012
CD4 is a receptor site on a host cell. HIV needs two receptor sites to allow for entry into a host cell. The other is CCR5. In one percent of the population, the allele responsible for expressing CCR5 is mutant and non-functioning, therefore HIV replication cannot occur and the body's natural defenses rid the bloodstream of the virus. Pfizer has developed a CCR5 blocker that may be the best line of offense against progression of the disease, and to my knowledge it is currently undergoing clinical trial, a long and tedious process that normally takes years. Prepare for an anouncement sooner than later.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.